SX2-22878-94573
3 vaccinations
1 coded response
6 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 462 / IN
- Registered
- 2022-12-02
- Relationship
- Child or adolescent in my care
- Guardian
- Z9P-83888-01795
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-22
Dose 1 — Pfizer-BioNTech
-
2022-08-19
Dose 2 — Pfizer-BioNTech
-
2022-11-11
Dose 3 — Pfizer-BioNTech
-
2022-12-02
Registered in v-safe
- 2022-12-02
-
2022-12-09
Survey response — day 28, dose 3, under 3MedDRA: Diarrhoea — Feeling: Good · Be unable to work or attend schoolFree text: DiarrheaMedDRA releases: 2024-11 · check-in free text available
- 2022-12-16
- 2022-12-23
- 2023-02-10
- 2023-05-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-22 | Pfizer-BioNTech | No |
| 2 | 2022-08-19 | Pfizer-BioNTech | No |
| 3 | 2022-11-11 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — day 28, dose 3, under 3
Symptoms: Diarrhea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release